{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:39:35Z","timestamp":1788043175523,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017521","name":"Esteve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neurom.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:09:29Z","timestamp":1776787769000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-Life Data on Ziconotide-Based Intrathecal Therapy in Patients With Cancer Pain: Interim Analysis of the Observational Practice in Clinics Registry"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-2130","authenticated-orcid":false,"given":"Denis","family":"Dupoiron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"Chvetzoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Seegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoufel","family":"Ouerchefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves-Marie","family":"Pluchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Julienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Jubier-Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Bienfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurom.2026.04.006_bib1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1273597","article-title":"Analgesia mediated by a direct spinal action of narcotics","volume":"192","author":"Yaksh","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.neurom.2026.04.006_bib2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neurom.2024.08.006","article-title":"The Polyanalgesic Consensus Conference (PACC)\u00ae: updates on clinical pharmacology and comorbidity management in intrathecal drug delivery for cancer pain","volume":"28","author":"Deer","year":"2024","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2026.04.006_bib3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.neurom.2024.03.003","article-title":"The Polyanalgesic Consensus Conference (PACC)\u00ae: intrathecal drug delivery guidance on safety and therapy optimization when treating chronic noncancer pain","volume":"27","author":"Deer","year":"2024","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2026.04.006_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2026.04.006_bib5","series-title":"Summary of product characteristics","year":"2014"},{"key":"10.1016\/j.neurom.2026.04.006_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.neurom.2026.04.006_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1016\/j.neurom.2026.04.006_bib8","article-title":"Intrathecal pain management with ziconotide: time for consensus?","volume":"11","author":"Matis","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.neurom.2026.04.006_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2011.10.002","article-title":"Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice","volume":"153","author":"Alicino","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.neurom.2026.04.006_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.36076\/ppj.2012\/15\/395","article-title":"Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol","volume":"15","author":"Dupoiron","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.neurom.2026.04.006_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0304-3959(99)00214-6","article-title":"Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats","volume":"84","author":"Wang","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neurom.2026.04.006_bib12","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/pm\/pnaa115","article-title":"Effectiveness and safety of intrathecal ziconotide: final results of the patient registry of intrathecal ziconotide management (PRIZM)","volume":"21","author":"McDowell","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.neurom.2026.04.006_bib13","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1097\/j.pain.0000000000001957","article-title":"Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial","volume":"161","author":"Ma","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.neurom.2026.04.006_bib14","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival","volume":"20","author":"Smith","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neurom.2026.04.006_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00000542-197902000-00013","article-title":"Pain relief by intrathecally applied morphine in man","volume":"50","author":"Wang","year":"1979","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurom.2026.04.006_bib16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.neurom.2021.12.004","article-title":"Management of cancer-related pain with intrathecal drug delivery: a systematic review and meta-analysis of clinical studies","volume":"26","author":"Perruchoud","year":"2023","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2026.04.006_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/AAP.0000000000000251","article-title":"Prospective observational study of patient-controlled intrathecal analgesia: impact on cancer-associated symptoms, breakthrough pain control, and patient satisfaction","volume":"40","author":"Brogan","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.neurom.2026.04.006_bib18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1213\/ANE.0000000000002903","article-title":"Intrathecal drug delivery systems for refractory pancreatic cancer pain: observational follow-up study over an 11-year period in a Comprehensive Cancer Center","volume":"126","author":"Carvajal","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurom.2026.04.006_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/rapm-2023-104961","article-title":"Intrathecal cervical analgesia for cancer pain: a 12-year follow-up study in a comprehensive cancer center","volume":"49","author":"Dupoiron","year":"2024","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.neurom.2026.04.006_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40122-020-00169-1","article-title":"Triple intrathecal combination therapy for end-stage cancer-related refractory pain: a prospective observational study with two-month follow-up","volume":"9","author":"Puntillo","year":"2020","journal-title":"Pain Ther"},{"issue":"suppl 4","key":"10.1016\/j.neurom.2026.04.006_bib21","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO clinical practice guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.neurom.2026.04.006_bib22","first-page":"674","article-title":"Spinal analgesia in cancer pain management-MASCC general practice recommendations","volume":"33","author":"Mercadante","year":"2025","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neurom.2026.04.006_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/ner.12486","article-title":"Use of low dose ziconotide as first-line intrathecal monotherapy","volume":"20","author":"Prusik","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2026.04.006_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pain.2011.10.028","article-title":"Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review","volume":"153","author":"Bennett","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neurom.2026.04.006_bib26","doi-asserted-by":"crossref","first-page":"E291","DOI":"10.36076\/ppj.2009\/12\/E291","article-title":"Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study","volume":"12","author":"Deer","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.neurom.2026.04.006_bib27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/papr.12438","article-title":"Clinical uses of intrathecal therapy and its placement in the pain care algorithm","volume":"16","author":"Pope","year":"2016","journal-title":"Pain Pract"},{"key":"10.1016\/j.neurom.2026.04.006_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/geriatrics7010006","article-title":"The impact of nursing staffs' working conditions on the quality of care received by older adults in long-term residential care facilities: a systematic review of interventional and observational studies","volume":"7","author":"Perruchoud","year":"2021","journal-title":"Geriatrics (Basel)"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715926000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715926000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:57:27Z","timestamp":1779825447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715926000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"alternative-id":["S1094715926000863"],"URL":"https:\/\/doi.org\/10.1016\/j.neurom.2026.04.006","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-Life Data on Ziconotide-Based Intrathecal Therapy in Patients With Cancer Pain: Interim Analysis of the Observational Practice in Clinics Registry","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurom.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Neuromodulation Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}